We have learned for decades that early intensive insulin therapy in patients with newly diagnosed T2D can bring favorable outcomes (Weng et al., 2008), while in T2D subjects with severe insulin resistance, high dose insulin treatment can be well‐tolerated and effective on improving glucose disposal (Kampmann et al., 2011). This evidence concerns the gene INS and Insulin resistance.